Factors involved in extracellular matrix turnover in human derived cardiomyocytes

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1125-1136

  Casals, Gregori ^a,b   Fernández Varo, Guillermo ^a,b,c   Melgar Lesmes, Pedro ^a,b   Marfà, Santi ^a,b   Reichenbach, Vedrana ^a,b   Morales Ruiz, Manuel ^a,b   Jiménez, Wladimiro ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apelin; Cardiomyocyte; HIF 1; Hypoxia; IL1 ; Matrix remodeling; TNF

Indexed keywords

APELIN; COLLAGEN TYPE 1; CYTOKINE; GELATINASE A; HYALURONIC ACID; HYPOXIA INDUCIBLE FACTOR; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; VASCULOTROPIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROGENESIS; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADULT; CELL HYPOXIA; COLLAGEN SYNTHESIS; GENE EXPRESSION; IN VITRO STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TURNOVER TIME;

CELL HYPOXIA; CELLS, CULTURED; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 2; MYOCYTES, CARDIAC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 84890728617     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354513     Document Type: Article

References (47)

1. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:569-582.
3. Spinale FG, Coker ML, Bond BR, Zellner JL: Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target. Cardiovasc Res 2000;46:225-238.
4. Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O: Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J 2012;33:2360-2369.
5. Siddiquee K, Hampton J, Khan S, Zadory D, Gleaves L, Vaughan DE, Smith LH: Apelin protects against angiotensin ii-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. J Hypertens 2011;29:724-731.
6. Davidson MM, Nesti C, Palenzuela L, Walker WF, Hernandez E, Protas L, Hirano M, Isaac ND: Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 2005;39:133-147.
7. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
8. Loboda A, Stachurska A, Florczyk U, Rudnicka D, Jazwa A, Wegrzyn J, Kozakowska M, Stalinska K, Poellinger L, Levonen AL, Yla-Herttuala S, Jozkowicz A, Dulak J: Hif-1 induction attenuates nrf2-dependent il-8 expression in human endothelial cells. Antioxid Redox Signal 2009;11:1501-1517.
9. Liu Y, Veena CK, Morgan JB, Mohammed KA, Jekabsons MB, Nagle DG, Zhou YD: Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (hif-1) activation by simultaneously targeting multiple pathways. J Biol Chem 2009;284:5859-5868.
10. Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007;87:1285-1342.
11. Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, Hapke E, Hauet AM, Escobar PG, Cleutjens JP, Smits JF, Daemen MJ, Zile MR, Spinale FG: Deficiency of timp-1 exacerbates lv remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2003;284:H364-371.
12. Madani S, De Girolamo S, Munoz DM, Li RK, Sweeney G: Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 2006;69:716-725.
13. Parkes JG, Liu Y, Sirna JB, Templeton DM: Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol 2000;32:233-246.
14. Vanhoutte D, Schellings M, Pinto Y, Heymans S: Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window. Cardiovasc Res 2006;69:604-613.
15. Hu CP, Dandapat A, Liu Y, Hermonat PL, Mehta JL: Blockade of hypoxia-reoxygenation-mediated collagen type i expression and mmp activity by overexpression of tgf-beta1 delivered by aav in mouse cardiomyocytes. Am J Physiol Heart Circ Physiol 2007;293:H1833-1838.
16. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, Soubrier F: Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 2008;103:432-440.
17. Han S, Wang G, Qi X, Lee HM, Englander EW, Greeley GH Jr: A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regul Integr Comp Physiol 2008;294:R1832-1839.
18. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T, Tsao PS: Hif-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 2007;293:E1590-1596.
19. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O, Tavi P: Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007;21:1821-1830.
20. Geiger K, Muendlein A, Stark N, Saely CH, Wabitsch M, Fraunberger P, Drexel H: Hypoxia induces apelin expression in human adipocytes. Horm Metab Res 2011;43:380-385.
21. Hausenloy DJ, Yellon DM: New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the reperfusion injury salvage kinase (risk)-pathway. Cardiovasc Res 2004;61:448-460.
22. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE, Patterson AJ, Anderson JP, Tsao PS, Lenardo MJ, Ashley EA, Quertermous T: Apelin signaling antagonizes ang ii effects in mouse models of atherosclerosis. J Clin Invest 2008;118:3343-3354.
23. Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, Johnston NR, Denvir MA, Megson IL, Flapan AD, Newby DE: Acute cardiovascular effects of apelin in humans: Potential role in patients with chronic heart failure. Circulation 2010;121:1818-1827.
24. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC: Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 2007;102:518-528.
25. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J, Beetz N, Musialek R, Neely GG, Komnenovic V, Kolm U, Metzler B, Ricci R, Hara H, Meixner A, Nghiem M, Chen X, Dawood F, Wong KM, Sarao R, Cukerman E, Kimura A, Hein L, Thalhammer J, Liu PP, Penninger JM: Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload. Circ Res 2007;101:e32-42.
26. Li L ZH, Chen JX: Apelin-13 increases myocardial progenitor cells and improves repair of post-myocardial infarction. Am J Physiol Heart Circ Physiol 2012;303:H605-618.
27. Dai Y XM, Wang Y, Pasha Z, Li T, Ashraf M: Hif-1alpha induced-vegf overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007;42:1036-1044.
28. Vera Janavel G CA, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M, Fernández N, Bercovich A, Criscuolo M, Melo C, Laguens R: Plasmid-mediated vegf gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther 2006;13:1133-1142.
29. Wang GL, Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 1993;82:3610-3615.
30. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA: Apelin, the ligand for the endothelial g-protein-coupled receptor, apj, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006;296:177-189.
31. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T: In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 2008;294:H88-98.
32. Semenza GL: Hif-1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-1480.
33. Bozkurt B, Mann DL, Deswal A: Biomarkers of inflammation in heart failure. Heart Fail Rev 2010;15:331-341.
34. Reddy VS, Prabhu SD, Mummidi S, Valente AJ, Venkatesan B, Shanmugam P, Delafontaine P, Chandrasekar B: Interleukin-18 induces emmprin expression in primary cardiomyocytes via jnk/sp1 signaling and mmp-9 in part via emmprin and through ap-1 and nf-kappab activation. Am J Physiol Heart Circ Physiol 2010;299:H1242-1254.
35. Waldenstrom A, Martinussen HJ, Gerdin B, Hallgren R: Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest 1991;88:1622-1628.
36. Hellman U, Malm L, Ma LP, Larsson G, Morner S, Fu M, Engstrom-Laurent A, Waldenstrom A: Growth factor pdgf-bb stimulates cultured cardiomyocytes to synthesize the extracellular matrix component hyaluronan. PLoS One 2010;5:e14393.
37. Pasqui AL, Di Renzo M, Auteri A, Puccetti L: Cytokines in acute coronary syndromes. Int J Cardiol 2005;105:355-356.
38. Rakhit RD, Seiler C, Wustmann K, Zbinden S, Windecker S, Meier B, Eberli FR: Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flow. Coron Artery Dis 2005;16:147-152.
39. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755.
40. Shames BD, Barton HH, Reznikov LL, Cairns CB, Banerjee A, Harken AH, Meng X: Ischemia alone is sufficient to induce tnf-alpha mrna and peptide in the myocardium. Shock 2002;17:114-119.
41. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, Ozdemir M: Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993;44:332-337.
42. Meldrum DR, Meng X, Dinarello CA, Ayala A, Cain BS, Shames BD, Ao L, Banerjee A, Harken AH: Human myocardial tissue tnfalpha expression following acute global ischemia in vivo. J Mol Cell Cardiol 1998;30:1683-1689.
43. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV: Cytokine signaling during myocardial infarction: Sequential appearance of il-1 beta and il-6. Am J Physiol 1995;269:R229-235.
44. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS, Valet P, Castan-Laurell I: Tnfalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 2006;20:1528-1530.
45. Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL, Quertermous T: Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol 2009;296:H1329-1335.
46. Maruyama K MY, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T: Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor kdr/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol 1999;31:607-617.
47. Tanaka T KH, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R, Kurabayashi M: Induction of vegf gene transcription by il-1 beta is mediated through stress-activated map kinases and sp1 sites in cardiac myocytes. J Mol Cell Cardiol 2000;32:1955-1967.